Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Pluripotent Stem Cell
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA Clears Gameto’s Fertilo for Phase 3 iPSC-Based Therapy Trial
Details : FDA has cleared its Investigational New Drug application for Fertilo, an iPSC-based therapy, it is being studied in improving pregnancy rate in comparison to traditional IVF procedure.
Product Name : Fertilo
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
January 30, 2025
Lead Product(s) : Pluripotent Stem Cell
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable